| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.0068 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.0066 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |